8th Nov 2006 15:06
Stem Cell Sciences plc08 November 2006 Immediate Release 8 November 2006 Stem Cell Sciences plc Stem Cell Sciences PLC (the "Company") NEW ISSUE AND SHARE BUYBACK The Company has made an application for 1 ordinary share of £0.01 ("New Share") to be admitted to the Alternative Investment Market ("AIM") on 9 November 2006. In addition the Company will buy back 22,301,194 Deferred Shares of £0.49 each (the "Buy-Back") with effect from 9 November 2006. The admission of the New Share and the Buy-Back are both required in connection with the capitalreorganisation of the Company pursuant to which each of the Company's Ordinary Shares, previously of 50p in nominal value, have been subdivided into one new Ordinary Share of 1p in nominal value and one Deferred Share of 49p in nominal value. All such Deferred Shares bought back by the Company have been cancelled. Shareholders should note that the reduction in the nominal value of each Ordinary Share does not result in a change in the number of Ordinary Shares in issue nor in any change in the underlying value of the business and assets ofthe Company. - Ends - For further information, please contact: Stem Cell Sciences plc 0131 662 9829Sue Furber, Director of Finance & Company Secretary Weber Shandwick | Square Mile 020 7067 0700Louise Robson This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SThree